InsidersTradesSigma
Track the 안트로젠 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 안트로젠 has recorded 1 reports. Market capitalisation: €162.8bn. The latest transaction was reported on 21 April 2026 (Purchase). Among the most active insiders: 이엠텍. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
안트로젠 是一家在XKRX市场上市的医疗保健和制药公司。它专注于生物疗法和创新药物的开发。